Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To evaluate the safety and tolerability of GS-9620 in adult subjects with chronic hepatitis B (CHB) infection who are currently not being treated -To evaluate the efficacy of GS-9620 as measured by the change from Baseline (BL) to Week 24 in serum Hepatitis B surface Antigen (HBsAg log10 IU/mL) levels
Critère d'inclusion
- Treatment of Subjects with Chronic Hepatitis B and who are currently not on Treatment